The U.S. Food and Drug Administration announced last week that a pharmaceutical company is removing a fentanyl patch from ...

Alvogen has issued a nationwide recall of one lot of Fentanyl Transdermal System 25 patches because the patches may stick ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl ...

The Aversa™ Fentanyl patch could generate significant annual sales, estimated between $80 million to $200 million. The company focuses on developing a portfolio of transdermal products that ...

an abuse deterrent fentanyl transdermal system, with the potential to become the first and only abuse deterrent pain patch on the market. Nutriband’s AVERSA™ abuse-deterrent technology can be ...

Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange ...

This technology can be incorporated into transdermal patches to prevent the abuse, diversion, misuse, and accidental exposure of drugs with abuse potential. Nutriband’s lead product under development ...

Nutriband Inc. has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, which combines Nutriband's abuse-deterrent technology with Kindeva's FDA-approved ...